Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-24-007251·PALVELLA THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Palvella Therapeutics Inc
Common stock, $0.001 par value per share · CUSIP: 697947109
Event date: 2024-12-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SUVRETTA CAPITAL MANAGEMENT, LLC
Shares: 714,463.00 · Class: 8.6%
- Averill Master Fund, Ltd.
Shares: 714,463.00 · Class: 8.6%
- Aaron Cowen
Shares: 714,463.00 · Class: 8.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-24-007251
- Form type
- SCHEDULE 13G
- Filer
- PALVELLA THERAPEUTICS, INC.
- CIK
- CIK 1583648
- Filed
- Dec 20, 2024
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13G beneficial ownership